These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 24273882

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 30. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P, Skoug JW, Nixon PR, Ju TR, Stemm NL, Sung KC.
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G, Wang R, Wang D, Zhang Z, Deng S.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T, De Beer T, Vervaet C, Remon JP.
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM, Campiñez MD, Pygall SR, Burley JC, Gupta P, Storey DE, Caraballo I, Melia CD.
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [Abstract] [Full Text] [Related]

  • 38. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
    Mitchell SA, Balwinski KM.
    J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
    Li L, Sun H, Gao J, Jiang T, Gao Y, Zhang J.
    Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.